UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Jonathan Said, MD

Print
Email

Jonathan Said, MD

UCLA Physician Jonathan Said, MD specializes in Anatomic Pathology & Clinical Pathology.
Specialty
Anatomic Pathology & Clinical Pathology
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
A34728
Contact
(310) 825-8940 Information
Email Address
jsaid@mednet.ucla.edu
Voted Best Doctor
PRACTICE LOCATION

UCLA Pathology & Lab Medicine
10833 Le Conte Ave 13-226 CHS
Los Angeles, CA 90095

MEDICAL BOARD CERTIFICATION
Clinical Pathology/Laboratory Medicine, American Board of Pathology, 1979
Pathology - Anatomic, American Board of Pathology, 1976
EDUCATION
Fellowship
Hematopathology, Brigham & Women's Hospital, 1976 - 1977
Residency
Pathology & Laboratory Med., Brigham & Women's Hospital, 1974 - 1976
Internship
Pathology & Laboratory Med., Boston Medical Center, 1973 - 1974
Rotating (Internship), Johannesburg General Hospital, 1972 - 1972
Medical Degree
MD, University of the Witwatersrand Medical School, 1971
AFFILIATION
Department Affiliation
Physician, Urology
MORE INFORMATION
Additional Information

Academic Title: Professor of Pathology and Laboratory Medicine

Department Titles:
Chief of Genitourinary Pathology
Director of Anatomic Pathology
Co-Director of Translational Pathology Core Laboratory, Tissue Procurement and Histology Core Laboratory Shared Resource
Member of ACCESS Program: Dept. of Cellular & Molecular Pathology
JCCC Hematopoietic Malignancies Program Area

Specialty: Hematopathology & Hematology, Anatomic Pathology, Surgical Pathology, Genitourinary Pathology

Publications

Link to all my PubMed publications.

  1. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, Koeffler HP Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis.. Blood. . 2005; 105(1): 376-81.
  2. Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.. Experimental hematology. . 2005; 33(1): 53-61.
  3. Takeuchi S, de Vos S, Takeuchi N, Fermin AC, Grogan TM, Seo H, Said JW, Koeffler HP Allelic loss during progression of follicular lymphoma.. Leukemia research. . 2004; 28(6): 567-9.
  4. Tsukasaki K, Tanosaki S, DeVos S, Hofmann WK, Wachsman W, Gombart AF, Krebs J, Jauch A, Bartram, CR, Nagai K, Tomonaga M, Said JW, Koeffler HP Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays.. International journal of cancer. Journal international du cancer. . 2004; 109(6): 875-81.
  5. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.. Cancer research. . 2004; 64(6): 1987-96.
  6. Kumagai, T Ikezoe, T Gui, D O'Kelly, J Tong, XJ Cohen, FJ Said, JW Koeffler, HP RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.. Clinical cancer research : an official journal of the American Association for Cancer Research. . 2004; 10(4): 1508-20.
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Jonathan Said,  click here to update your profile.